Genome editing in the mammalian brain using the CRISPR-Cas system

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Genome editing technologies, including CRISPR-Cas9, have revolutionized biomedical research by enabling efficient genetic modification.
• Previous limitations in brain applications, particularly in postmitotic neurons, hindered neuroscience research.
• In vivo genome editing in somatic cells offers potential for correcting genetic defects in human diseases.

Purpose of the Study:

• To review the development of genome editing technologies specifically for the brain.
• To discuss the applications, limitations, and future challenges of these technologies in neuroscience.
• To highlight recent advances overcoming barriers to brain genome editing.

Main Methods:

• Review of recent technological advancements in genome editing for neural applications.
• Analysis of genome editing efficiency in both mitotic and postmitotic neurons, in vitro and in vivo.
• Discussion of CRISPR-associated endonuclease Cas9 and related tools.

Main Results:

• Recent advances have significantly improved the efficiency and precision of genome editing in the brain.
• Technologies now allow precise genome modification in both dividing and non-dividing mature neurons.
• These advancements facilitate the study of gene function and dysfunction in neurological contexts.

Conclusions:

• Genome editing technologies are now powerful tools for neuroscience research, enabling in vivo studies.
• Overcoming previous limitations opens new avenues for understanding and potentially treating brain disorders.
• Continued development is crucial for fully realizing the potential of genome editing in the brain.